FDA’s Sentinel initiative
This article was originally published in The Tan Sheet
Executive Summary
FDA will tap Medicare Part D's large-scale claims database for the pilot phase of its Sentinel post-market drug safety surveillance initiative, Health and Human Services Secretary Mike Leavitt announced May 22. The Sentinel initiative aims to create a national electronic system for monitoring the safety of drugs and devices, and will also incorporate elements of FDA's Adverse Event Reporting system (1"The Tan Sheet" Feb. 20, 2006, p. 5). A 2white paper also released May 22 does not indicate when a full-scale network of participants will be ready, but notes the agency will start using Part D data as soon as practicable to launch the project...
You may also be interested in...
AERs To Go Online: Drug Safety Budget Proposal Funds Web Version
FDA is proposing increased drug safety funding to launch its web-accessible, second-generation Adverse Event Reporting System
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.